Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AvenActive: Safety, Tolerability, and PK of Avenanthramide
NCT06101784Phase 2Completed
- Sponsor
- Montréal Heart Institute
- Start
- Dec 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oat avenanthramides in inflammation, sponsored by Montréal Heart Institute. Started Dec 2023; status: completed.
02
Drugs
oat avenanthramides
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT06101784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06101784.